The FDA approval was based on data from a randomized, multi-arm, controlled clinical trial (n=1,879) that showed using Tegaderm CHG IV Securement Dressing lowered CRBSI by 60% in patients with ...

Tegaderm CHG I.V. Securement Dressing meets the CDC’s highest evidence-based recommendation category, IA, meaning it is a strong recommendation supported by high-to-moderate quality ...

Tegaderm Antimicrobial I.V. Advanced Securement Dressing is designed to minimize catheter movement and dislodgement. This addition to 3M antimicrobial PIV care and maintenance products ...

Tegaderm ® application was associated with significantly lower daily weight loss throughout the first week of life (P=0.04; data not shown). TEG infants also regained their birth weight faster ...